1. Home
  2. ATR vs KRYS Comparison

ATR vs KRYS Comparison

Compare ATR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AptarGroup Inc.

ATR

AptarGroup Inc.

HOLD

Current Price

$131.65

Market Cap

9.3B

Sector

Industrials

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$258.84

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATR
KRYS
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
7.8B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
ATR
KRYS
Price
$131.65
$258.84
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$170.25
$297.60
AVG Volume (30 Days)
420.7K
223.8K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.46%
N/A
EPS Growth
6.51
128.00
EPS
5.89
6.84
Revenue
$3,777,181,000.00
$389,130,000.00
Revenue This Year
$5.29
$39.88
Revenue Next Year
$4.98
$34.38
P/E Ratio
$22.33
$37.88
Revenue Growth
5.42
33.94
52 Week Low
$103.23
$123.03
52 Week High
$164.28
$298.30

Technical Indicators

Market Signals
Indicator
ATR
KRYS
Relative Strength Index (RSI) 56.73 50.48
Support Level $129.06 $255.65
Resistance Level $133.25 $263.75
Average True Range (ATR) 2.93 8.83
MACD 1.13 1.43
Stochastic Oscillator 90.78 55.94

Price Performance

Historical Comparison
ATR
KRYS

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: